Top

Published in:

Open Access 01-01-2021 | Colonoscopy | Review

Prospective observational data informs understanding and future management of Lynch syndrome: insights from the Prospective Lynch Syndrome Database (PLSD)

Authors: Toni T. Seppälä, Mev Dominguez-Valentin, Julian R. Sampson, Pål Møller

Published in: Familial Cancer | Issue 1/2021

Abstract

The Prospective Lynch Syndrome Database (PLSD) has been developed as an international, multicentre, prospective, observational study that aims to provide age and organ-specific cancer risks according to gene and gender, estimates of survival after cancer and information on the effects of interventions. Recent reports from PLSD provided improved estimates of cancer risks and survival and showed that different time intervals between surveillance colonoscopies did not affect the incidence, stage or prognosis of colorectal cancer. The PLSD reports suggest that current management guidelines for Lynch syndrome should be revised in light of the different gene and gender-specific cancer risks and the good prognosis for the most commonly associated cancers.

In this review, we describe the discrepancies between the current management guidelines for Lynch Syndrome and the most recent prospective observational studies, indicating the areas of further research.

Møller P (2020) The Prospective Lynch Syndrome Database reports enable evidence-based personal precision health care. Hered Cancer Clin Pract 18:6. https://doi.org/10.1186/s13053-020-0138-0CrossRefPubMedPubMedCentral

Møller P, Seppälä T, Bernstein I et al (2017) Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database. Gut 66:464–472. https://doi.org/10.1136/gutjnl-2015-309675CrossRefPubMed

Dominguez-Valentin M, Sampson JR, Seppälä TT et al (2020) Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database. Genet Med 22:15–25. https://doi.org/10.1038/s41436-019-0596-9CrossRefPubMed

Engel C, Vasen HF, Seppälä T et al (2018) No difference in colorectal cancer incidence or stage at detection by colonoscopy among 3 countries with different Lynch Syndrome Surveillance Policies. Gastroenterology 155:1400–1409.e2. https://doi.org/10.1053/j.gastro.2018.07.030CrossRefPubMed

Møller P, Seppälä TT, Bernstein I et al (2018) Cancer risk and survival in path-MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database. Gut 67:1306–1316. https://doi.org/10.1136/gutjnl-2017-314057CrossRefPubMed

Järvinen HJ, Aarnio M, Mustonen H et al (2000) Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118:829–834. https://doi.org/10.1016/s0016-5085(00)70168-5CrossRefPubMed

Dowty JG, Win AK, Buchanan DD et al (2013) Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat 34:490–497. https://doi.org/10.1002/humu.22262CrossRefPubMed

Järvinen HJ, Mecklin JP, Sistonen P (1995) Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 108:1405–1411. https://doi.org/10.1016/0016-5085(95)90688-6CrossRefPubMed

Seppälä T, Pylvänäinen K, Evans DG et al (2017) Colorectal cancer incidence in path_MLH1 carriers subjected to different follow-up protocols: a Prospective Lynch Syndrome Database report. Hered Cancer Clin Pract 15:18. https://doi.org/10.1186/s13053-017-0078-5CrossRefPubMedPubMedCentral

10.

Seppälä TT, Ahadova A, Dominguez-Valentin M et al (2019) Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report. Hered Cancer Clin Pract 17:8. https://doi.org/10.1186/s13053-019-0106-8CrossRefPubMedPubMedCentral

11.

Dominguez-Valentin M, Seppälä TT, Sampson JR et al (2019) Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report. Hered Cancer Clin Pract 17:28. https://doi.org/10.1186/s13053-019-0127-3CrossRefPubMedPubMedCentral

12.

Latchford A (2020) How should colonoscopy surveillance in Lynch syndrome be performed? Gastroenterology. https://doi.org/10.1053/j.gastro.2019.12.022CrossRefPubMed

13.

Rahmi G, Lecomte T, Malka D et al (2015) Impact of chromoscopy on adenoma detection in patients with lynch syndrome: a prospective, multicenter, blinded, tandem colonoscopy study. Am J Gastroenterol 110:288–298. https://doi.org/10.1038/ajg.2014.423CrossRefPubMed

14.

Perrod G, Samaha E, Rahmi G et al (2018) Impact of an optimized colonoscopic screening program for patients with Lynch syndrome: 6-year results of a specialized French network. Therap Adv Gastroenterol 11:1–10. https://doi.org/10.1177/1756284818775058CrossRef

15.

Cellier C, Perrod G, Colas C et al (2019) Back-to-back comparison of colonoscopy with virtual chromoendoscopy using a third-generation narrow-band imaging system to chromoendoscopy with indigo carmine in patients with Lynch syndrome. Am J Gastroenterol. https://doi.org/10.14309/ajg.0000000000000386CrossRefPubMed

16.

Haanstra JF, Dekker E, Cats A et al (2019) Effect of chromoendoscopy in the proximal colon on colorectal neoplasia detection in Lynch syndrome: a multicenter randomized controlled trial. Gastrointest Endosc 90:624–632. https://doi.org/10.1016/j.gie.2019.04.227CrossRefPubMed

17.

Lappalainen J, Holmström D, Lepistö A et al (2019) Incident colorectal cancer in Lynch syndrome is usually not preceded by compromised quality of colonoscopy. Scand J Gastroenterol 54:1473–1480. https://doi.org/10.1080/00365521.2019.1698651CrossRefPubMed

18.

Engel C, Ahadova A, Seppälä TT et al (2020) Associations of pathogenic variants in MLH1, MSH2, and MSH6 with risk of colorectal adenomas and tumors and with somatic mutations in patients with Lynch syndrome. Gastroenterology 158:1326–1333. https://doi.org/10.1053/j.gastro.2019.12.032CrossRefPubMed

19.

Zadro JR, Farey J, Harris IA, Maher CG (2019) Do choosing wisely recommendations about low-value care target income-generating treatments provided by members? A content analysis of 1293 recommendations. BMC Health Serv Res 19:707. https://doi.org/10.1186/s12913-019-4576-1CrossRefPubMedPubMedCentral

20.

Møller P, Seppälä T, Bernstein I et al (2017) Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database. Gut 66:1657–1664. https://doi.org/10.1136/gutjnl-2016-311403CrossRefPubMed

21.

Crosbie EJ, Ryan NAJJ, Arends MJ et al (2019) The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome. Genet Med 21:2390–2400. https://doi.org/10.1038/s41436-019-0489-yCrossRefPubMedPubMedCentral

22.

Renkonen-Sinisalo L, Sipponen P, Aarnio M et al (2002) No support for endoscopic surveillance for gastric cancer in hereditary non-polyposis colorectal cancer. Scand J Gastroenterol 37:574–577. https://doi.org/10.1080/00365520252903134CrossRefPubMed

23.

Haanstra JF, Al-Toma A, Dekker E et al (2015) Prevalence of small-bowel neoplasia in Lynch syndrome assessed by video capsule endoscopy. Gut 64:1578–1583. https://doi.org/10.1136/gutjnl-2014-307348CrossRefPubMed

24.

Haanstra J, Al-Toma A, Dekker E et al (2017) Incidence of small bowel neoplasia in Lynch syndrome assessed by video capsule endoscopy. Endosc Int Open 05:E622–E626. https://doi.org/10.1055/s-0043-111723CrossRef

25.

Mankaney G, Macaron C, Burke CA (2020) Refining risk factors for gastric cancer in patients with Lynch syndrome to optimize surveillance esophagogastroduodenoscopy. Clin Gastroenterol Hepatol 18:780–782. https://doi.org/10.1016/j.cgh.2019.10.003CrossRefPubMed

26.

Canto MI, Almario JA, Schulick RD et al (2018) Risk of neoplastic progression in individuals at high risk for pancreatic cancer undergoing long-term surveillance. Gastroenterology 155:740–751.e2. https://doi.org/10.1053/j.gastro.2018.05.035CrossRefPubMedPubMedCentral

Title: Prospective observational data informs understanding and future management of Lynch syndrome: insights from the Prospective Lynch Syndrome Database (PLSD)
Authors: Toni T. Seppälä
Mev Dominguez-Valentin
Julian R. Sampson
Pål Møller
Publication date: 01-01-2021
Publisher: Springer Netherlands
Keywords: Colonoscopy
Colorectal Cancer
Colorectal Cancer
Published in: Familial Cancer / Issue 1/2021
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI: https://doi.org/10.1007/s10689-020-00193-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2021

Complete response of hereditary leiomyomatosis and renal cell cancer (HLRCC)-associated renal cell carcinoma to nivolumab and ipilimumab combination immunotherapy by: a case report

Report of the fifth meeting of the European Consortium 'Care for CMMRD' (C4CMMRD), Leiden, The Netherlands, July 6th 2019

Germline variants discovered in lymphoma patients undergoing tumor profiling: a case series

Low accuracy of self-reported family history of melanoma in high-risk patients

New surveillance guidelines for Li-Fraumeni and hereditary TP53 related cancer syndrome: implications for germline TP53 testing in breast cancer

Chemoprevention in familial adenomatous polyposis: past, present and future

Keynote webinar | Spotlight on antibody–drug conjugates in cancer